New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →
Product
AI Sales Agents Prospector Intent & Signals Visitor Tracking Reply Handler Email Automation LinkedIn Automation Autopilot
Solutions
TAM sourcing Automated outbound Sales RevOps Enterprise Startups
Resources
The Report AI SDR Benchmark Blog Salestools University Guides GPT Prompts ROI Calculator Help Center
Company
Our Team Careers Customers Partner Program Pricing Changelog
Language
Get a demo Start free trial Log in

Le rapport

Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde

230 rapports et plus encore

Mis à jour quotidiennement avec les dernières informations de marché
Biotech
Candid Therapeutics

Candid Therapeutics raises $370M Series A at $1.2B valuation

Candid Therapeutics raises $370M in Series A at $1.2B valuation. Developing novel therapeutics for autoimmune diseases...

Editorial Team
Sep 9, 2024
0 min read•$370M
Fundraising
Candid Therapeutics

Candid Therapeutics Raises $370M in Series A

Candid Therapeutics, a Biotech company based in San Francisco, CA, has raised $370M in Series A at a $1.2B valuation led by Venrock, Fairmount, TCGX.

Fundraising News Team
Sep 9, 2024
0 min read
Biotechnology
Kailera Therapeutics

Kailera Therapeutics Raises $400 Million in Series A - October 2024

Kailera Therapeutics announced $400 Million in Series A funding at a Undisclosed valuation. Kailera Therapeutics raised a massive $400 million Series A to develop clinical-stage injectable and oral therapies for chronic weight management and ...

James Rodriguez
Oct 26, 2025
0 min read•$400 Million
Biotechnology
Electra Therapeutics

Electra Therapeutics Raises $183 Million in Series C - October 22, 2024

Electra Therapeutics announced $183 Million in Series C funding at a Undisclosed valuation. Electra Therapeutics raised an oversubscribed $183 million Series C to advance clinical trials for novel immunology therapies targeting autoimmune and...

James Rodriguez
Oct 26, 2025
0 min read•$183 Million
Fundraising
Candid

Candid Raises $200M in Series D

Candid, a AI/ML company based in San Francisco, CA, has raised $200M in Series D at a $1.5B valuation led by General Catalyst, Index Ventures.

Fundraising News Team
Aug 27, 2025
0 min read
AI/ML
Candid

Candid raises $200M Series D at $1.5B valuation

Candid raises $200M in Series D at $1.5B valuation. AI for business intelligence...

Editorial Team
Aug 27, 2025
0 min read•$200M
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Page 1

Affichage de 9 rapports • Page 1 • Catégorie : all

Restez en avance sur le marché

Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.